Why Integra Lifesciences Stock Is Sinking Today
Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the market opened.
Integra reported Q2 revenue of $418.2 million, up 9.7% year over year. This topped the average analyst revenue estimate of nearly $413.2 million.
The company posted a loss per share of $0.16, based on generally accepted accounting principles (GAAP). Integra announced adjusted earnings per share (EPS) of $0.63. Although this reflected a decline from adjusted EPS of $0.71 in the prior-year period, it narrowly beat the consensus estimate of $0.62.
Source Fool.com
Integra LifeSciences Holdings Corp Aktie
23,00 €
-20,69 %
Unentschieden bei Integra LifeSciences Holdings Corp: 3 Buy- stehen 4 Sell-Einschätzungen gegenüber.
Obwohl das Kursziel für Integra LifeSciences Holdings Corp bei 24 € liegt, was über dem aktuellen Kurs von 23.0 € ist, zeigt sich ein Potenzial von 4.35%.
